Document Detail


Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
MedLine Citation:
PMID:  20482238     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the effectiveness of a Q-switched Nd:YAG laser (MedLite C6; HOYA ConBio, Fremont, CA, USA) and 7% alpha arbutin solution (Skin Advance Laboratory, Japan) in the treatment of melasma. METHODS: This was a prospective study of 35 refractory melasma cases treated with 10 weekly laser sessions, two monthly follow-up treatments and topical 7% alpha arbutin solution. Clinical photographs and severity grading on a 5-point scale were carried out by an independent observer at each visit. RESULTS: At 6 months, 30% of study subjects received results in the excellent clearance category (> 81% reduction of melasma) and 36.7% received good (51-80% reduction) clearance. Mild and transient side effects included discomfort during treatment, erythema, whitening of fine hair and urticaria. Three cases of mottling hypo-pigmentation (8.57%) and two cases of recurrence of melasma (5.71%) were recorded. CONCLUSION: Combination therapy with the MedLite C6 and 7% alpha arbutin solution is an effective and well-tolerated treatment for refractory melasma.
Authors:
Niwat Polnikorn
Related Documents :
16098018 - Copper-replacement treatment for symptomatic menkes disease: ethical considerations.
16908348 - Description and management of cutaneous side effects during cetuximab or erlotinib trea...
11226988 - Surgical correction of buried penis: a review of 60 cases.
18569258 - Facial skin tightening with an 1100-1800 nm infrared device.
15709138 - Aneurysmal subarachnoid hemorrhage: management strategies and clinical outcomes in a re...
7524508 - Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with ...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology     Volume:  12     ISSN:  1476-4180     ISO Abbreviation:  J Cosmet Laser Ther     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-20     Completed Date:  2010-08-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136419     Medline TA:  J Cosmet Laser Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  126-31     Citation Subset:  IM    
Affiliation:
Kasemrad Aesthetic Center, Kasemrad Prachacheun Hospital, Bangsue, Bangkok, Thailand. niwatpol@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Arbutin / therapeutic use*
Combined Modality Therapy
Female
Humans
Laser Therapy, Low-Level* / adverse effects
Lasers, Solid-State / adverse effects,  therapeutic use*
Melanosis / radiotherapy*
Middle Aged
Prospective Studies
Chemical
Reg. No./Substance:
497-76-7/Arbutin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Journal of Cosmetic and Laser Therapy. Editorial.
Next Document:  Treatment of infantile hemangioma with optimal pulse technology.